Condition
Recurrent Urinary Tract Infections in Women
Total Trials
5
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 2 (2)
P 3 (1)
Trial Status
Recruiting2
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07194941Phase 2CompletedPrimary
Efficacy and Safety of Fecal Microbiota Transfer (FMT) for Recurrent Urinary Tract Infections in Women
NCT07184827Phase 3RecruitingPrimary
Evaluate the Efficacy and Safety of U101 Oral Capsules in the Prevention of Uncomplicated rUTIs in Women
NCT06940622Not ApplicableRecruiting
A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections
NCT03032003Not ApplicableUnknownPrimary
Prophylactic Use of Cranberries in Recurrent Bacterial Cystitis in Women
NCT00261248Phase 2CompletedPrimary
Vaccine for Recurrent Urinary Tract Infections in Women
Showing all 5 trials